Cambrex Invests $120 Million to Enhance API Production and US Drug Supply Stability Cambrex announces a significant $120 million investment to strengthen its US API manufacturing capacity, boosting the pharmaceutical supply chain's resilience and meeting rising demand.

Cambrex Invests $120 Million to Enhance API Production and US Drug Supply Stability #United_States #Cambrex #East_Rutherford #API_Production #US_Drug_Supply